Provention Bio PRVB

$ 24.98 0.0%

Annual report 2022
added 03-29-2023

Provention Bio Financial Statements 2011-2024 | PRVB

Annual Financial Statements Provention Bio

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.79 B	355 M	889 M	645 M	51.3 M	-	-	-	-	-	-	-
Shares	74.7 M	63.1 M	52.5 M	40.7 M	22.4 M	-	-	-	-	-	-	-
Historical Prices	23.9	5.62	16.9	14.9	1.77	-	-	-	-	-	-	-
Net Income	-114 M	-114 M	-98.6 M	-43.3 M	-26.5 M	-9.13 M	-	-	-	-	-	-
Revenue	12.9 M	1.4 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-128 M	-116 M	-99.7 M	-44.4 M	-26.8 M	-9.14 M	-	-	-	-	-	-
Interest Expense	1.04 M	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-128 M	-115 M	-99.7 M	-44.4 M	-26.3 M	-9.01 M	-	-	-	-	-	-
Operating Expenses	141 M	117 M	99.7 M	44.4 M	26.8 M	-	-	-	-	-	-	-
General and Administrative Expenses	64.1 M	47.3 M	33.3 M	8.01 M	4.16 M	1.46 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Provention Bio

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	83.1 M	-	63.4 M	63.4 M	63.4 M	63.4 M	62.3 M	56.5 M	56.3 M	49.2 M	47.7 M	47.7 M	40.5 K	37.4 K	37.4 K	37.4 M	32 M	10 M	10 M	10 M	10 M	9.47 M	-	7.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-28.6 M	-	-22 M	-	-27 M	-29.1 M	-32.4 M	-	-31.3 M	-22.1 M	-12.6 M	-	-9.77 M	-12 M	-11 M	-	-5.39 M	-10.3 M	-5.06 M	-	-1.36 M	-4.04 M	-	-165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	756 K	-	580 K	-	678 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-29.1 M	-	-29.1 M	-	-27.1 M	-30.2 M	-32.5 M	-	-31.4 M	-22.8 M	-12.9 M	-	-9.97 M	-12.3 M	-11.3 M	-	-5.41 M	-10.2 M	-5.04 M	-	-1.38 M	-3.99 M	-	-165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	255 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-29 M	-	-28.9 M	-	-27 M	-30.1 M	-32.4 M	-	-31.4 M	-22.8 M	-12.9 M	-	-9.97 M	-12.3 M	-11.3 M	-	-5.41 M	-10.2 M	-5.04 M	-	-1.38 M	-3.99 M	-	-165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	29.8 M	-	29.7 M	-	27.8 M	30.2 M	32.5 M	-	31.4 M	22.8 M	12.9 M	-	9.97 M	12.3 M	11.3 M	-	5.41 M	10.2 M	5.04 M	-	1.38 M	3.99 M	-	165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	13.5 M	-	12.3 M	-	10 M	13.2 M	12.8 M	-	9.75 M	7.76 M	3.78 M	-	2.65 M	1.71 M	1.24 M	-	1.27 M	1 M	653 K	-	488 K	256 K	-	165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency